Demographic, Clinical, and Ocular Features in Patients with Late-onset Behçet Disease

REFERENCES

• Mochizuki M, Akduman L, Nussenblatt RB. Behçet’s disease. In Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis: Mosby; 1996: 663–675.
   Google Scholar
• International Study Group for Behçet’s Disease. Evaluation of diagnostic (‘classification’) criteria in Behçet’s disease: toward internationally agreed criteria. Lancet. 1990;335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–1291.
   PubMed Web of Science ®Google Scholar
• Poon W, Verity DH, Larkin GL, et al. Behçet’s disease in patients of West African and Afro-Caribbean origin. Br J Ophthalmol. 2003;87:876–878.
   PubMedGoogle Scholar
• Yazici H, Tuzun Y, Pazarli H. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43: 783–789.
   PubMed Web of Science ®Google Scholar
• Citirik M, Berker N, Songur MS, et al. Ocular manifestations of late-onset Behçet disease. Ophthalmologica. 2011;225:21–26.
   PubMed Web of Science ®Google Scholar
• Krause I, Uziel Y, Guedj D. Childhood Behçet’s disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999;38:457–462.
   PubMed Web of Science ®Google Scholar
• Zafirakis P, Foster CS. Adamantiades-Behçet disease. In Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: Saunders; 2002: 632–652.
   Google Scholar
• Altenburg A, Papoustis N, Orawa H, et al. Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany: current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges. 2006;4:49–65.
   PubMedGoogle Scholar
• Ando K, Fujino Y, Hijikata K, et al. Epidemiological features and visual prognosis of Behçet’s disease. Jpn J Ophthalmol. 1999;43:312–317.
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Kötter I, Djawari D, et al. Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J. 1997;38:411–422.
   PubMedGoogle Scholar
• Matsuo T, Itami M, Nakagawa H. The incidence and pathology of conjunctival ulceration in Behçet’s syndrome. Br J Ophthalmol. 2002;86:140–143.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Whitcup SM, Palestine AG. Behçet’s disease. In Nussenblatt RB, Whitcup SM, Palestine AG, eds. Uveitis: Fundamentals and Clinical Practice. St Louis: Mosby; 1996: 334–353.
   Google Scholar
• Colvard DM, Robertson DM, O’Duffy JD. The ocular manifestations of Behçet’s disease. Arch Ophthalmol. 1977;95:1813–1817.
   PubMedGoogle Scholar
• Zamir E, Bodaghi B, Tugal-Tutkun I. Conjunctival ulcers in Behçet’s disease. Ophthalmology. 2003;110:1137–1141.
   PubMed Web of Science ®Google Scholar
• Atmaca LS. Fundus changes associated with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol. 1989;227:340–344.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycıoglu R. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373–380.
   PubMed Web of Science ®Google Scholar
• Sungur GK, Hazirolan D, Yalvac I, et al. Clinical and demographic evaluation of Behçet disease among different paediatric age groups. Br J Ophthalmol. 2009;93:83–87.
   PubMed Web of Science ®Google Scholar
• Fujikawa S, Suemitsu T. Behçet’s disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39:285–289.
   PubMedGoogle Scholar
• Tsai J, Chen GS, Lu LW et al. Late-onset Behçet’s disease does not correlate with indolent clinical course: report of seven Taiwanese patients. J Eur Acad Dermatol Venereol. 2008;22:596–600.
   PubMed Web of Science ®Google Scholar
• Saricaoglu H, Karadogan SK, Bayazit N. Clinical features of late-onset Behçet’s disease: report of nine cases. Int J of Dermatol. 2006;45:1284–1287.
   PubMed Web of Science ®Google Scholar
• Sungur G, Hazirolan D, Hekimoglu E, et al. Late-onset Behçet’s disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol. 2010;248:1325–1330.
   PubMed Web of Science ®Google Scholar
• Main DM, Chamberlain MA. Clinical differentiation of oral ulceration in Behçet’s disease. Br J Rheumatol. 1992;31:767.
   PubMedGoogle Scholar
• Deuter CM, Kötter I, Wallace GR, et al. Behçet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27:111–136.
   PubMed Web of Science ®Google Scholar
• Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3:148–155.
   PubMedGoogle Scholar
• Magro CM, Crowson AN. Cutaneous manifestations of Behçet’s disease. Int J Dermatol. 1995;34:159.
   PubMed Web of Science ®Google Scholar
• Yazici H, Chamberlain MA, Tuzun Y, et al. A comparative study of the pathergy reaction among Turkish and British patients with Behçet’s disease. Ann Rheum Dis. 1984;43:74–75.
   PubMed Web of Science ®Google Scholar
• O’Duffy JD. Vasculitis in Behçet’s disease. Rheumatol Dis Clin North Am. 1990;16:423–431.
   PubMed Web of Science ®Google Scholar
• Kidd D, Steuer A, Denman AM, et al. Neurological complications in Behçet’s syndrome. Brain. 1999;122:2183–2194.
   PubMed Web of Science ®Google Scholar
• Ebert EC. Gastrointestinal manifestations of Behçet’s disease. Dig Dis Sci. 2009;54:201–207.
   PubMedGoogle Scholar
• Padula A, Ciancio G, Cantini F, et al. Coexisting Behçet’s disease and spondyloarthritis. Clin Rheumatol. 1999;18:499–500.
   PubMedGoogle Scholar
• Evereklioglu C. Current concepts in the etiology and the treatment of Behçet disease. Surv Ophthalmol. 2005;50:297.
   PubMed Web of Science ®Google Scholar
• Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet’s disease in Turkey. Ophthalmology. 1997;104:701–705.
   PubMed Web of Science ®Google Scholar
• Ozdal PC, Ortac S, Taskintuna I. Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol. 2002;12:424–431.
   PubMed Web of Science ®Google Scholar
• Taylor SR, Singh J, Menezo V, et al. Behçet disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol. 2011;152:1059–1066.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Shahram F, Shams H, et al. Gender influence on ocular manifestations and their outcome in Behcet’s Disease: a long-term follow-up of up to 20 years. Clin Rheumatol. 2011;30:541–547.
   PubMed Web of Science ®Google Scholar
• Sáenz-Francés F, Elías-de-Tejada M, Martínez-de-la-Casa JM, et al. Ocular inflammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular inflammation. Eur J Ophthalmol. 2008 Jul–Aug;18(4):563–566.
   PubMedGoogle Scholar
• Koh HJ. Ophthalmologic manifestation of Behcet’s disease. In Bang D, Lee E, Lee S, eds. Behcet’s Disease. Seoul: Design Mecca; 2000: 90–93.
   Google Scholar